GFAP and multiple system atrophy: This is in line with another recent in vivo cross-sectional study also using an ultra-sensitive immunoassay for detection of GFAP in CSF [16], while earlier in vivo studies were not able to detect differences in CSF GFAP levels between MSA and HC [30, 31], possibly due to limited assay sensitivity.